Medicare Enrolled

Dr. Angela Harris, PA-C

Medical Physician Assistant · Dearborn, MI
Low-engagement
3133 S TELEGRAPH RD, Dearborn, MI 48124
3135656566
In practice since 2013 (12 years)
NPI: 1144656935 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Harris

Dr. Angela Harris is a medical physician assistant in Dearborn, MI, with 12 years of NPI registration.

Between the years covered by Open Payments, Dr. Harris received a total of $4,978 from 50 pharmaceutical and/or device companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Harris is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice $4,978 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,978
Total received (2021-2024)
Avg $1,244/year across 4 years
Top 9% in MI for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
315
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,978 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,064
2023
$982
2022
$1,217
2021
$1,715

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$153
Lilly USA, LLC
$84
Novo Nordisk Inc
$84
PFIZER INC.
$72
Phathom Pharmaceuticals, Inc.
$69
Abbott Laboratories
$57
GlaxoSmithKline, LLC.
$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$50
Tolmar, Inc.
$48
Amgen Inc.
$46
AstraZeneca Pharmaceuticals LP
$43
Takeda Pharmaceuticals U.S.A., Inc.
$39
Exact Sciences Corporation
$30
Indivior Inc.
$29
Neurocrine Biosciences, Inc.
$23
Azurity Pharmaceuticals, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$22
Otsuka America Pharmaceutical, Inc.
$21
Astellas Pharma US Inc
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
GENZYME CORPORATION
$18
Currax Pharmaceuticals LLC
$16
Bausch Health US, LLC
$16
Dexcom, Inc.
$16
Radius Health, Inc.
$14
Top 3 companies account for 30.3% of 2024 payments
All-time payments by company (2021-2024) ›
Amgen Inc.
$606
Novo Nordisk Inc
$592
Lilly USA, LLC
$393
PFIZER INC.
$392
SANOFI-AVENTIS U.S. LLC
$294
ABBVIE INC.
$234
Novartis Pharmaceuticals Corporation
$203
Janssen Pharmaceuticals, Inc
$200
GlaxoSmithKline, LLC.
$171
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$146
Amarin Pharma Inc.
$138
ARBOR PHARMACEUTICALS, INC.
$130
IDORSIA PHARMACEUTICALS US INC
$118
AstraZeneca Pharmaceuticals LP
$110
Takeda Pharmaceuticals U.S.A., Inc.
$73
Abbott Laboratories
$73
Phathom Pharmaceuticals, Inc.
$69
Bayer HealthCare Pharmaceuticals Inc.
$64
Azurity Pharmaceuticals, Inc.
$59
Sumitomo Pharma America, Inc.
$56
Kowa Pharmaceuticals America, Inc.
$55
Orexo US, Inc.
$53
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$50
Biohaven Pharmaceuticals, Inc.
$49
Tolmar, Inc.
$48
Neurocrine Biosciences, Inc.
$44
AbbVie Inc.
$43
DEXCOM, INC.
$39
Otsuka America Pharmaceutical, Inc.
$36
Lundbeck LLC
$35
Dexcom, Inc.
$32
Merck Sharp & Dohme LLC
$30
Exact Sciences Corporation
$30
Indivior Inc.
$29
Biohaven Pharmaceutical Holding Company Ltd.
$28
Nestle HealthCare Nutrition Inc.
$28
Alkermes, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Astellas Pharma US Inc
$21
GENZYME CORPORATION
$18
Teva Pharmaceuticals USA, Inc.
$17
Currax Pharmaceuticals LLC
$16
Bausch Health US, LLC
$16
Eisai Inc.
$15
Covis Pharma GmBH
$15
Radius Health, Inc.
$14
Merck Sharp & Dohme Corporation
$14
Almatica Pharma LLC
$13
SANOFI PASTEUR INC.
$13
Phadia US Inc.
$12
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · AIRSUPRA · ALVESCO · ANORO ELLIPTA · APLENZIN · Aimovig · AirDuo Digihaler · BAQSIMI · BELSOMRA · BREZTRI · CAPLYTA · CERDELGA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Enbrel · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 3 · GEMTESA · Horizant · INGREZZA · ImmunoCAP · JARDIANCE · JATENZO · Kerendia · LEQVIO · LINZESS · LOREEV XR · LYBALVI · Livalo · MOUNJARO · NEXIUM · NURTEC ODT · Otezla · Ozempic · PREMARIN · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SUBLOCADE · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TZIELD · Tymlos · UBRELVY · VOQUEZNA · VPRIV · VRAYLAR · VYEPTI · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · ZENPEP · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for medical physician assistant in MI.

Looking for a medical physician assistant in Dearborn?
Compare medical physician assistants in the Dearborn area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
527
Per 100K population
29.7
County median income
$59,521
Nearest hospital
BEAUMONT HOSPITAL - DEARBORN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Harris is a medical physician assistant, with low-engagement industry engagement in the top 9% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Harris receive payments from pharmaceutical companies?
Yes. Dr. Harris received a total of $4,978 from 50 companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Harris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →